Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

Stopped Till interim analysis, 100 cases were enrolled, 71 of which during the COVID-19. Affected by epidemic control policy, 58 cases had examination window exceeded or missed, causing significant impact on endpoints, so we decided to terminate the trial.

Conditions

• Hypertension
• Blood Pressure
• Cardiovascular Diseases

Interventions

• DEVICE: focused power ultrasound mediate inferior perirenal adipose tussue modification
• DEVICE: sham-control group

Sponsor

The First Affiliated Hospital with Nanjing Medical University